Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UIC Center Funds 7 Projects with Potential for Human Therapies

04.03.2009
The University of Illinois at Chicago Center for Clinical and Translational Science has awarded $515,000 over two years to seven UIC research projects with great potential to move from laboratory to clinical investigation.

The center's pilot grant program looks for UIC projects that involve human subjects or facilitate human subject investigations and have clear, near-term implications for therapeutics or prevention.

The seven projects were chosen from 75 proposals submitted by investigators from 17 different departments and four colleges.

"The large number of meritorious applications for this grant cycle made the selection process tough," said center director Dr. Theodore Mazzone. "But it speaks well of the potential for UIC to continue to expand its footprint in clinical translational research."

The one- and two-year pilot grants will support early investigations vital to securing long-term funding for cutting-edge research. The program is funded by the UIC Office of the Provost, the Office of the Vice Chancellor for Research, and UIC's six health science colleges.

One pilot grant will develop a collaborative research program in asthma and allergic diseases. Steven J. Ackerman, professor of biochemistry and molecular genetics, will act as principal investigator on the project,

"Mast Cell, Macrophage, and Eosinophil Interactions in Asthma," with co-investigators Dr. John Christman, professor of pulmonary, critical care and sleep medicine; Richard Ye, professor of pharmacology, and H. Ari Jaffe, associate professor of pulmonary, critical care and sleep medicine.

A simple case of the flu can pose a deadly threat to people whose immune system is suppressed to prevent rejection of a transplanted organ. One pilot grant will explore a promising immunotherapy to treat severe infections in patients with compromised immune systems. Marlene Bouvier, associate professor of microbiology and immunology, will act as principal investigator on the project, "T-cell Immunotherapy for Adenoviral Infections of Hematopoietic Stem Cell Transplant Patients," with co-investigator Dr. James Cook, professor of infectious diseases.

Studies of human cancers begin in tissue culture, but often cells grown in a Petri dish won't continue to behave and respond like a natural cell in the body. As a result, it becomes almost impossible to learn how these cells become cancerous. One pilot grant will obtain a type of ovarian cell that is the progenitor of 90 percent of all ovarian cancers and develop a three-dimensional system that allows the cells to live and grow normally. Joanna E. Burdette, assistant professor of medicinal chemistry and pharmacognosy, will act as principal investigator with co-investigator Dr. Nita Lee, assistant professor in obstetrics and gynecology.

A project bringing together research expertise from three UIC medical campuses -- Chicago, Urbana-Champaign and Rockford -- will focus on a multi-disciplinary approach to improving cancer care for rural residents. Michael Glasser, associate dean for rural health professions at the UIC College of Medicine at Rockford, will act as principal investigator while Usha Menon, associate professor of biobehavioral health science in the College of Nursing and Lissette Piedra, assistant professor of social work at Urbana-Champaign are co-investigators.

A pilot grant that will produce the first human data from the multi-electrode electroretinogram will show this promising diagnostic tool's potential for mapping retinal health. Ophthalmologists hope that meERG will aid in early detection of a number of blinding diseases, including retinitis pigmentosa, age-related macular degeneration, and diabetic retinopathy. John Hetling, associate professor of bioengineering, is principal investigator on the grant, "Novel Electroretinographic Mapping of Retinal Function for Diagnosis of Progressive Eye Disease," and co-investigator is Janet Szlyk, professor of ophthalmology and visual sciences.

Beta-blockers are the major therapy used to treat ischemic heart diseases, which affect an estimated 14 million Americans. But a quarter of patients can't tolerate beta-blockers -- asthma patients, for example, can suffer life-threatening airway constriction. One pilot grant will explore alternative drug candidates in animal and human tissue systems based on previous study of signaling pathways in cardiac cells. Yunbo Ke, research assistant professor of physiology and biophysics, and R. John Solaro, professor physiology and biophysics will act as co-principal investigators on the grant, "Activation of P21 Activated Kinase-1 as a Novel Therapeutic Strategy for Ischemic Heart Diseases" with Dr. Samuel C. Dudley, professor of cardiology, as co-investigator.

Malignant gliomas are among the most lethal brain tumors, with a high rate of recurrence despite surgery, radiation and chemotherapy. Tumor cells are believed to hide out in areas of the brain called white-matter fiber tracts, allowing the tumor to regrow following treatment. Xiaohong Joe Zhou, associate professor of neurological surgery, will act as principal investigator in a project to determine whether a specialized magnetic resonance imaging technique can identify white-matter fiber tracts that have been invaded by tumor cells. His co-investigators on the project, "A Pilot Study of White Matter Involvement in Glioma Patients Using High-Resolution Diffusion MRI," are Dr. Herbert H. Engelhard, associate professor of neurological surgery; Dr. John L. Villano, assistant professor of oncology; and Dr. Tibor Valyi-Nagy, associate professor of pathology.

Jeanne Galatzer-Levy | Newswise Science News
Further information:
http://www.uic.edu

More articles from Science Education:

nachricht How Humans and Machines Navigate Complex Situations
19.11.2018 | Max-Planck-Institut für Bildungsforschung

nachricht A gene activated in infant and young brains determines learning capacity in adulthood
13.11.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Science Education >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nonstop Tranport of Cargo in Nanomachines

Max Planck researchers revel the nano-structure of molecular trains and the reason for smooth transport in cellular antennas.

Moving around, sensing the extracellular environment, and signaling to other cells are important for a cell to function properly. Responsible for those tasks...

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Optical Coherence Tomography: German-Japanese Research Alliance hosted Medical Imaging Conference

19.11.2018 | Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

 
Latest News

Sustainable energy supply in developing and emerging countries: What are the needs?

21.11.2018 | Power and Electrical Engineering

Nonstop Tranport of Cargo in Nanomachines

20.11.2018 | Life Sciences

Researchers find social cultures in chimpanzees

20.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>